NCT03527771 is a NA clinical trial of Video-assisted CPR in Cardiac Arrest, sponsored by University of Cologne.

Who is sponsoring NCT03527771?

NCT03527771 is sponsored by University of Cologne.

What drugs are being tested in NCT03527771?

Interventions in NCT03527771: Video-assisted CPR, telephone-assisted CPR.

What condition does NCT03527771 study?

NCT03527771 studies Cardiac Arrest.

Is NCT03527771 still recruiting?

NCT03527771 is currently completed. Last updated 31 August 2018.

Last reviewed 2018-08-31 · How we verify

NCT03527771

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Video-assisted Telephone CPR With the EmergencyEye-Software - a Pilot Study

Completed NA Last updated 31 August 2018

What this trial tests

NA trial testing Video-assisted CPR in Cardiac Arrest in 150 participants. Completed in 28 August 2018.

Timeline

8 August 2018

Primary endpoint
28 August 2018

28 August 2018

Quick facts

Lead sponsor	University of Cologne
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	150
Start date	8 August 2018
Primary completion	28 August 2018
Estimated completion	28 August 2018
Sites	1 location across Germany

Drugs / interventions tested

Video-assisted CPR
telephone-assisted CPR — full drug profile →

Conditions studied

Cardiac Arrest — all drugs for Cardiac Arrest →

Sponsor

University of Cologne

Who can join

Adults 18 to 65, any sex, with Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Technical advance as broad-bandwidth wireless internet coverage and the ubiquity utilization of smartphones has opened up new possibilities which surpass the normal audio-only telephony. High quality and real-time video-telephony is now feasible. However until now this technology hasn't been deployed in the emergency respond service. In the hope of helping the detection of the cardiac arrest, offer the possibility to evaluate and correct via a video-instructed CPR (V-CPR) and to facilitate a fast localization of the emergency site, a new software (EmergencyEye®/RAMSES®) was developed which enables the dispatcher a video-telephony with the callers mobile terminal (smartphone) if suitable. This technology hasn't been tested in a randomized controlled trail yet and no data exists that shows if V-CPR in comparison to T-CPR and non-instructed CPR leads to a better bystander CPR-performance.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Video-assisted cardiopulmonary resuscitation via smartphone improves quality of resuscitation: A randomised controlled simulation trial.
Ecker H, Lindacher F, Adams N, Hamacher S, et al · · 2020 · cited 27× · PMID 32073408 · DOI 10.1097/eja.0000000000001177
Dispatcher Self-assessment and Attitude Toward Video Assistance as a New Tool in Simulated Cardiopulmonary Resuscitation.
Ecker H, Wingen S, Hagemeier A, Plata C, et al · · 2022 · cited 8× · PMID 35302457 · DOI 10.5811/westjem.2021.12.53027

Verify or expand the search:

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

NCT07239206 — Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses · NA · recruiting
NCT06780722 — Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced · recruiting
NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
NCT06511999 — Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest · recruiting
NCT07113769 — Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation · recruiting

Other University of Cologne trials

Trials by the same sponsor.

NCT07280585 — STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease · Phase 3 · recruiting
NCT06612515 — Vaccine-induced Immunity in Immunocompromised Patients · recruiting
NCT06781710 — Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Synd · recruiting
NCT05969431 — Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study · recruiting
NCT05876221 — Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03527771 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Cologne
Last refreshed: 31 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03527771.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing